retatrutide weight loss clinical results just delivered one of the largest weight-loss signals we've ever seen in a medication trial. In a phase 2 study: • Up to 24.2% mean at 48 weeks Retatrutide Phase 3: TRIUMPH Program

Slowing the ramp to the label cadence (2.5 mg start, 2.5 mg steps, four-week holds) dropped that to mid-single digits at every maintenance dose, at no cost to the 12-week result, and the dedicated slow-titration trial reached placebo range. Reaching 15 mg is not the problem

GLP-1s can cause fatigue or nausea in some people, so pace yourself accordingly

Understanding that diarrhea is a predictable pharmacological response, not a sign of danger, helps you approach symptom management with confidence

This chart shows clinical trial protocols and is for informational purposes only

How sweet a food tastes is one of the biggest changes